Cogent Biosciences Inc. (cogt 1.625 11/15/31)
13F holders, Q4 2025 (December 31)2holders
$1.17avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Cogent Biosciences Inc. (cogt 1.625 11/15/31) in their 13F filings. The largest holders were Polar Capital Holdings Plc ($6.4M) and NewEdge Advisors, LLC ($15K).
- Company
- Cogent Biosciences Inc. (cogt 1.625 11/15/31)
- CUSIP
- 19240QAA0
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $6.5M |
| Exits | 0 | $0 |
Ownership 2 holders
| Polar Capital Holdings Plc | 0.03% | New | 5,500,000 | $6.4M |
| NewEdge Advisors, LLC | 0.00% | New | 13,000 | $15K |
"% of holder's portfolio" is COGENT BIOSCIENCES INC (COGT 1.625 11/15/31)'s weight in each manager's 13F, not the share of Cogent Biosciences Inc. (cogt 1.625 11/15/31) the manager owns.